Orrick has advised San Francisco-based synthetic biology company Twist Bioscience (NASDAQ: TWST) on its $107.4 million follow-on offering.
by Denise Mingrone | August.31.2020
by Catherine Y. Lui | August.24.2020
by Richard Smith | July.06.2020
| September.09.2020Orrick announced today that Shana Solomon, a seasoned advisor to companies in the life science, biotechnology and pharmaceutical industries, has ...
| September.09.2020Orrick announced today that technology transactions advisor Faraaz Samadi has joined the firm as a partner in London. He is the 9th addition to ...
The latest trade secret news and analysis from the U.S. and across the globe.
Trends in cybersecurity, data privacy and compliance
The Recorder, 2016
Investor AllStars, 2017
Law360, 4 times
The American Lawyer, 2016
Law360, 2018 and 3 times